1. Home
  2. HIHO vs BDRX Comparison

HIHO vs BDRX Comparison

Compare HIHO & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

HOLD

Current Price

$0.83

Market Cap

4.8M

Sector

Industrials

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$3.32

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
BDRX
Founded
1990
2000
Country
Hong Kong
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HIHO
BDRX
Price
$0.83
$3.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.0K
2.6M
Earning Date
12-15-2025
09-12-2025
Dividend Yield
14.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,143,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$3.55
52 Week High
$2.05
$92.00

Technical Indicators

Market Signals
Indicator
HIHO
BDRX
Relative Strength Index (RSI) 15.86 41.73
Support Level $1.12 $4.55
Resistance Level $1.28 $7.22
Average True Range (ATR) 0.07 1.51
MACD -0.03 -0.18
Stochastic Oscillator 11.76 2.09

Price Performance

Historical Comparison
HIHO
BDRX

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: